Interesting tactic to consider
Forum rules
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
-
jayfish101
- Posts: 331
- Joined: Tue Feb 23, 2016 5:48 pm
Interesting tactic to consider
Inspire Medical Systems (NASDAQ: INSP) faces heightened execution risk following a sharp 2025 earnings guidance cut tied to weak Inspire V adoption and operational missteps, including staffing and billing issues; the resulting class-action lawsuits underscore investor concerns about management credibility and the company's ability to restore growth through effective commercialization. Shares closed up 31% at $117.29.